期刊文献+

干眼患者泪液及外周血中白细胞介素-6表达水平检测及相关研究 被引量:10

Clinical analysis of interleukin-6 level in tear and serum of dry eye patient
下载PDF
导出
摘要 背景干眼发病机制尚未完全明确,越来越多的研究证实炎症在干眼的发生发展中起重要作用,但炎性因子白细胞介素-6(IL-6)与干眼的关系尚待证实。目的检测干眼患者泪液及外周血中IL-6的表达水平,探讨其与临床症状及体征的关联性。方法收集确诊的Sjogren综合征(SS)患者、非Sj^gren综合征(NSS)患者各20例20眼,另收集健康志愿者20人20眼为正常对照组。所有受检者接受干眼症状调查量表评分及泪膜破裂时间(BUT)、泪液分泌试验I(SIt)、角膜荧光素染色检查。采用ELISA法检测受检者外周血及泪液中IL-6的表达水平,并与临床症状和体征进行Spearman秩相关分析。结果ss组、NSS组及正常对照组干眼症状评分分别为18.50(11.75,23.00)、23.00(19.00,32.00)、2.00(0.25,4.00),SS组、NSS组的干眼症状评分明显高于正常对照组,差异均有统计学意义(P=0.00、0.00);3个组BUT值分别为2.50(2.00,3.88)、3.50(2.13,4.00)、15.00(13.13,17.00)S,SS组、NSS组的BUT值均明显低于正常对照组,差异均有统计学意义(P=0.00、0.00);3个组SIt值分别为2.00(1.50,2.88)、4.00(3.00,5.75)、19.00(18.00,25.00)mm,SIt值正常对照组〉NSS组〉SS组,差异均有统计学意义(均P=0.00);角膜荧光素染色评分分别为5.75(4.00,7.75)、4.50(3.63,6.00)、0.00(0.00,0.75),SS组、NSS组角膜荧光素染色评分均明显高于正常对照组,差异均有统计学意义(P=0.00、0.00)。SS组、NSS组及正常对照组外周血中IL-6质量浓度分别为(131.47±21.04)、(77.81±15.68)、(31.62±8.57)μg/L,泪液中IL-6质量浓度分别为(33.44±8.01)、(18.78±5.73)、(8.77±3.43)p^g/L,正常对照组〈NSS组〈SS组,差异均有统计学意义(均P=0.00)。外周血及泪液中IL-6质量浓度与干眼症状评分、角膜荧光素染色评分均呈正相关(均P=0.00),与BUT和sIt结果均呈负相关(均P=0.00)。结论干眼患者外周血及泪液中IL-6质量浓度升高,并与干眼的临床症状和体征相关,是反映疾病严重程度的客观、敏感和可靠的标志物。 Background Mechanism of dry eye disease has not been established clearly. Some increasing evidences showed that inflammation plays an important role in pathogenesis and development of dry eye disease. However,the association of interleukin-6 (IL-6) with dry eye has not been clarified. Objective This study was to assess the correlation of IL-6 levels in tear and serum of patient with dry eye disease and clinical symptom. Methods Twenty patients with Sj^gren syndrome (SS) and 20 cases with non-Sjtigren syndrome (NSS) were enrolled from Second Affiliated Hospital of Nanjing Medical University, and 20 healthy volunteers were recruited as the normal controls. Symptom questionnaires were self-answered and multiple dry eye-related clinical tests were performed,including tear film breakup time (BUT) ,Schirmer I test (S I t) and corneal fluorescence staining. IL-6 concentrations in serum and tear were detected by enzymedinked immunosorbent assay (ELASA). The correlation between IL-6 level and tear film and ocular surface parameters was analyzed by Spearman rank correlation. Written informed consent was obtained from each subject initial of this trial. Results The scores of symptom questionnaires were 18.50 (11.75,23.00),23.00 (19.00,32.00) and 2.00 (0.25,4.00) in the SS group,NSS group and the normal control group, and significantly increasing values were seen in the SS group and NSS group compared with the normal control group (P=0. 00,0. 00). BUT values in the SS group and NSS group were 2.50 (2.00,3.88) seconds and 3.50 (2. 13,4.00) seconds and were lower than 15.00 (13. 13,17.00) seconds in the normal control group (P=0. O0,0. O0).S I I values in lhe SS group,NSS group and the normal control group were 2.00 (1.50,2.88), 4.00 (3.00,5.75) and 19.00 (18.00,25.00)ram,showing significant differences between the SS group and the ,~ormal control group (P=0.00),the SS group and the NSS group (P=0.00) or the NSS group and the normal control group (P = O. 00). The marked elevation of keratoepithelioplasty score was seen between the SS group and the normal control group (5.75(4.00,7.75) vs.0.00(0.00,0.75) (P=0.00) or the NSS group and the normal control group (4.50 (3.63,6.00) vs. 0.00 ( O. 00,0.75 ) ) ( P = 0.00 ). Concentrations of IL-6 in serum and tear in the SS group, NSS group were ( 131.47±21.04 )μg/L and ( 77. 81 ± 15.68 ) μg/L and were significantly higher than ( 31.62± 8.57)μg/l, ofthe normal control group,and those in the tear were (33.44±8.01)μg/L,(18.78±5.73)μg/L and (8.77± 3.43)μg/L, respectively in the three groups, with a significant reduce in the normal control group (all P=0.00). IL-6 levels in serum and tear were positively correlated with the score of symptom questionnaires or keratoepilhelioplasty and negatively correlated with BUT and S I t (all P=0.00). Conclusions IL-6 levels in the tear and serum of the dry eye patient are associated with the severity of the disease. IL-6 levels in serum and tear may be objective ,sensitive and reliable indicators of dry eye.
出处 《中华实验眼科杂志》 CAS CSCD 北大核心 2013年第2期186-190,共5页 Chinese Journal Of Experimental Ophthalmology
基金 南京医科大学重点课题基金项目(2010NJMUZ01)
关键词 干眼 炎症 细胞因子 白细胞介素-6 酶联免疫吸附试验 Dry eye Inflammation Cytokine Interleukin-6 Enzyme-linked immunosorbent assay
  • 相关文献

参考文献15

  • 1Pflugfelder SC. Antiinflammatory therapy for dry eye[J].American Journal of Ophthalmology,2004,(2):337-342.doi:10.1016/j.ajo.2003.10.036.
  • 2Vitali C,Bombardieri S,Jonsson R. Classification criteria for Sj(o)gren's syndrome:a revised version of the European criteria proposed by the American-European Consensus Group[J].Annals of the Rheumatic Diseases,2002.554-558.
  • 3刘祖国,彭娟.干眼的诊断与治疗规范[J].眼科研究,2008,26(3):161-164. 被引量:282
  • 4Sahai A,Malik P. Dry eye:prevalence and attributable risk factors in a hospital-based population[J].Indian Journal of Ophthalmology,2005.87-91.
  • 5Kassan SS,Moutsopoulos HM. Clinical manifestations and early diagnosis of Sj(o)gren syndrome[J].Archives of Internal Medicine,2004.1275-1284.
  • 6Stern ME,Gao J,Schwalb TA. Conjunctival T-cell subpopulationsin Sj(o)gren's and non-Sj(o)gren's patients with dry eye[J].Investigative Ophthalmology & Visual Science,2002.2609-2614.
  • 7Oshida T,Iwata M,Sakimoto T. Tumor necrosis factor-alpha in tears of patients with Sj(o)gren syndrome[J].Nihon Ganka Gakkai Zasshi,2004.297-301.
  • 8Turner K,Pflugfelder SC,Ji Z. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion[J].Cornea,2000.492-496.
  • 9Rolando M,Barabino S,Mingari C. Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes[J].Cornea,2005,(8):951-954.doi:10.1097/01.ico.0000157421.93522.00.
  • 10Solomon A,Dursun D,Liu Z. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease[J].Investigative Ophthalmology & Visual Science,2001.2283-2292.

二级参考文献24

  • 1Kawai M,Yamada M,Kawashima M,et al.Quantitative evaluation of tear meniscus height from fluorescein photographs[J].Cornea,2007,26(4):403-406.
  • 2Németh J,Erdélyi B,Csákány B,et al.High-speed videotopographic measurement of tear film build-up time[J].Invest Ophthalmol Vis Sci,2002,43(6):1783-1790.
  • 3Srinivasan S,Chan C,Jones L.Apparent time-dependent differences in inferior tear meniscus height in human subjects with mild dry eye symptoms[J].Clin Exp Optom,2007,90(5):345-350.
  • 4Yokoi N,Komuro A.Non-invasive methods of assessing the tear film[J].Exp Eye Res,2004,78(3):399-407.
  • 5Yokoi N,Takehisa Y,Kinoshita S.Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye[J].Am J Ophthalmol,1996,122 (6):818-824.
  • 6McMonnies CW.Key questions in a dry eye history[J].J Am Optom Assoc,1986,57(7):512-517.
  • 7Bron AJ,Evans VE,Smith JA.Grading of corneal and conjunctival staining in the context of other dry eye tests[J].Cornea,2003,22(7):640-650.
  • 8Toda I,Fujishima H,Tsubota K.Ocular fatigue is the major symptom of dry eye[J].Acta Ophthalmol (Copenh),1993,71(3):347-352.
  • 9Kelly K,Nichols J,Jason J,et al.The lack of association between signs and symptoms in patients with dry eye disease[J].Cornea,2004,23(8):762-770.
  • 10Schein OD,Tielsch JM,Mun(o)z B,et al.Relation between signs and symptoms of dry eye in the elderly.A population based perspective[J].Ophthalmology,1997,104(9):1395-1401.

共引文献298

同被引文献110

  • 1张南生,陈瑞杰,张秀华.利福平不良反应的文献分析[J].中国临床药学杂志,2005,14(5):312-315. 被引量:31
  • 2宋秀君,庞润晖.干眼与相关细胞因子的研究进展[J].河北医药,2006,28(12):1203-1205. 被引量:8
  • 3张鹏,孟春梅,李德强,邱明才.RT-PCR法研究糖尿病大鼠视网膜上TNFα mRNA的表达[J].天津医药,2007,35(8):603-605. 被引量:3
  • 4Nelson JD. Impression cytology[J]. Cornea, 1988,17 ( 1 ) :71- 81.
  • 5Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study [ J ]. Ophthaimology, 2003, 110 ( 6 ) : 1096- 1101.
  • 6Abelson MB,Ousler GW 3rd,Maffei C. Dry eye in 2008[ J]. Curr Opin Ophthalmol, 2009,20 ( 4 ) : 282-286.
  • 7Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders [ J ]. Br J Ophthalmol, 2004, 88( 11 ) : 1467-1474.
  • 8Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized come-control study[J]. Am J Ophthalmol,2005,139(2) :242-246.
  • 9Huang WC, Chiang CC, Tsai YY. Autologous serum eye drops for treating persistent corneal epithelial defect after vitreoretinal surgery[ J]. Cornea ,2008,27 ( 9 ) : 1097.
  • 10Lavaju P, Sharma M, Sharma A, Chettri S. Use of amniotic mem- brane and autologous serum eye drops in Mooren' s ulcer[J]. Nepal J Ophthalmol, 2013,5 ( 9 ) : 120-123.

引证文献10

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部